Business Wire

Generate:Biomedicines Appoints Dr. Alexandra Snyder as Executive Vice President, Research & Development

SOMERVILLE, Mass.--(BUSINESS WIRE)--Generate:Biomedicines today announced that Dr. Alexandra (Alex) Snyder has been appointed to Executive Vice President, Research & Development, in addition to her ...
Business Wire

Generate Biomedicines Grows Leadership Team with Head of Vaccines and Infectious Disease Research and Senior Vice President of Technical Operations

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Generate Biomedicines today announced that Daria Hazuda, Ph.D., has been named Head of Vaccines and Infectious Disease Research and Lisa Wyman has been named Senior ...
GEN

Novartis, Generate:Biomedicines Sign Up-to-$1B AI Protein Drug Collaboration

Novartis will apply Generate:Biomedicines’ generative artificial intelligence (AI) platform to discover and develop protein therapeutics for multiple unspecified disease areas, through a collaboration ...